23andMe to Discontinue Access to Health-Related Genetic Tests During FDA Regulatory Review

23andMe today announced that it will comply immediately with the U.S. Food and Drug Administration's directive to discontinue consumer access to its … 23andMe today announced that it will comply immediately with the U.S. Food and Drug Administration's directive to discontinue consumer access to its health-related genetic tests during the ongoing regulatory review process. The company will continue to provide consumers both ancestry-related information and raw genetic data without interpretation. In addition, the company will continue to conduct research using its database of genetic and phenotypic data, and also will continue its educational efforts. “We remain firmly committed to fulfilling our long-term mission to help people everywhere have access to their own genetic data and have the ability to use that information to improve their lives,” said Anne